Increased Expression of AXL and c‐MET in High‐Grade Clear Cell Renal Cell Carcinoma and Its Association With VEGFR‐TKI Treatment and PD‐L1 Expression

Documenti analoghi

• Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
  di: Yuta Kaneko, et al.
  Pubblicazione: (2024)
• Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence
  di: Ayuna Sugai, et al.
  Pubblicazione: (2025)
• Prognostically Significant Glycan Profiles of Clear Cell Renal Cell Carcinoma Identified by Integrated Glycome–Methylome Analysis
  di: Yoshiko Kitazume, et al.
  Pubblicazione: (2025)
• Comparison of Histologic Parameters and Predictive Gene Signatures in Clear Cell Renal Cell Carcinoma Response to Systemic Therapy
  di: Chisato Ohe, et al.
  Pubblicazione: (2025)
• Immunoreactivities of ZCCHC3 and Efp in the High‐Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors
  di: Erina Iwabuchi, et al.
  Pubblicazione: (2026)